1. Home
  2. Upgrades


Curaleaf Price Target Spikes, Fueled By German Cannabis Legalization Changes — ROTH MKM Explains

Strategic Outlook And Earnings Forecast According to ROTH MKM, a privately held investment banking company, cannabis multi-state operator Curaleaf Holdings, Inc. (CSE: CURA) (OTC: CURLF) is poised to unveil its fourth-quarter earnings for 2023 on March 6, with projections indicating a modest rise in revenue and EBITDA. This anticipated growth is credited to Curaleaf’s strategic positioning […]

LendingTree’s Growth in Insurance and SEM Advertising Positions for Multi-Year Cycle, Says Analyst

Keefe, Bruyette & Woods analyst Ryan Tomasello upgraded LendingTree, Inc. (NASDAQ:TREE) from Market Perform to Outperform, raising the forecast to $45 from $24. Per Tomasello, the 2024 earnings recovery for LendingTree is led by a rebound in the company’s insurance segment, where 2024 guidance could be conservative. Going ahead, the analyst forecasts that insurance segment revenue/profit will surpass prior peaks […]

Why This Apollo Global Management Analyst Is Now Bullish

Apollo Global Management’s (NYSE: APO) chief economist recently expressed skepticism around AI (artificial intelligence) being a bubble. The company is a leader in the alternative asset management space and seems well-positioned for growth in private credit, according to JPMorgan. The Apollo Global Management Analyst: Kenneth Worthington upgraded the rating Apollo Global Management from Neutral to […]

Unity Software Downgraded On Heels Of Portfolio Reset, 5 Analysts Provide Key Takeaways

Shares of Unity Software Inc (NYSE: U) tanked in early trading on Tuesday, after the company reported a higher-than-expected loss for the fourth quarter. The results came amid an exciting earnings season. Here are some key analyst takeaways from the release. Piper Sandler analyst Brent Bracelin upgraded the rating from Underweight to Neutral, while raising […]

Fox Will See Big Win from New Sports Joint Venture: Analyst

Citigroup analyst Jason Bazinet upgraded Fox Corp (NASDAQ:FOXA) from Neutral to Buy and raised the price target from $34 to $35. On February 6, 2024, Walt Disney Co (NYSE:DIS), Fox, and Warner Bros Discovery, Inc (NASDAQ:WBD) announced a sports joint venture encompassing ~50% of US sports rights.  The analyst’s analysis shows that the JV will be a positive for Fox. As such, he modestly […]

Block Inc Q4 Earnings Preview: Eyes On Rule Of 40, Growth, Profitability And More

Fintech Block Inc (NYSE:SQ) is set to report fourth quarter financial results after market close Thursday. Here’s an overview of analyst predictions, their insights before the quarterly report, and crucial points for investors to watch. Earnings Estimates: Analysts expect Block to report fourth quarter revenue of $5.70 billion, according to data from Benzinga Pro. The […]

Broadcom, The Magnificent 7 Stock In Waiting: Can The Chipmaker Replace EV Carmaker Tesla?

While Elon Musk-owned electric vehicle maker Tesla Inc (NASDAQ:TSLA) has slumped 22% into 2024, the shares of semiconductor maker Broadcom Inc (NASDAQ:AVGO) have rallied 10%. This is significant because the slump in Tesla’s shares combined with the growth in Broadcom’s shares means the chipmaker is now only a short way behind Musk’s company in terms […]

ARS Pharma Readies Data In Response To FDA’s Rejection For Its EpiPen Alternative For Severe Allergic Reactions

Tuesday, ARS Pharmaceuticals Inc (NASDAQ:SPRY) released topline results from its clinical study comparing repeat doses of neffy (epinephrine nasal spray) to repeat doses of epinephrine intramuscular (IM) injection. ARS Pharma intends to submit this repeat-dose NAC study data to the FDA as part of its response to the CRL early in the second quarter of 2024. The randomized, crossover […]